Search company, investor...

Founded Year

2011

Stage

Seed VC - II | Alive

Total Raised

$3.68M

About OCON Medical

OCON Healthcare develops, manufactures, and commercializes cutting-edge women’s health products based on its patented IUB (Intra Uterine Ball) proprietary platform. The IUB, made from a super-elastic alloy Nitinol, is an ideal carrier for multiple drugs to the uterus to treat a variety of conditions. It was founded in 2011 and is based in Modi'ln, Israel.

Headquarters Location

Hamiktso’ot Blvd. 14 15 Hashdera Hamerkazit

Modi'In, 7178095,

Israel

+972 72 21 50 105

Loading...

OCON Medical's Product Videos

Hormonal-Ballerine.jpg

OCON Medical's Products & Differentiators

    IUB SEAD

    OCON's IUB SEAD is a single-use, once-and-done method for endometrial ablation using silver nitrate beads that dissolve within 30 min. Simple and quick approach for AUB & HMB, which affects 1 in 3-4 women – now treated with either harmful hormones with recognized side effects or aggressive ablation therapies that may lead to hysterectomies. SEAD is a disruptive, non-hormonal, in-office, cost-effective solution. It is currently in phase IIb clinical studies.

Loading...

OCON Medical Patents

OCON Medical has filed 7 patents.

The 3 most popular patent topics include:

  • dosage forms
  • gynaecology
  • drug delivery devices
patents chart

Application Date

Grant Date

Title

Related Topics

Status

1/14/2022

5/9/2023

Gynaecology, Progestogens, Hormonal contraception, Women's health, Dosage forms

Grant

Application Date

1/14/2022

Grant Date

5/9/2023

Title

Related Topics

Gynaecology, Progestogens, Hormonal contraception, Women's health, Dosage forms

Status

Grant

Latest OCON Medical News

Intrauterine Contraceptive Devices (IUD) Market size to grow by USD 965.49 million between 2022 and 2027; AbbVie Inc., Bayer AG, DKT International among others, identified as key vendors - Technavio

May 15, 2023

News provided by Share this article Share this article NEW YORK, May 14, 2023 /PRNewswire/ -- The intrauterine contraceptive devices (IUD) market  size is estimated to grow by USD 965.49 million during 2023-2027. However, the growth momentum will be progressing at a CAGR of 3.98%  during the forecast period. The market is segmented by Type (Hormonal intrauterine device and Copper intrauterine device), End-user (Hospitals, Gynecology Clinics, and Others), and Geography (North America, Europe, APAC, and Rest of the World (ROW)). The intrauterine devices market share growth by the hormonal intrauterine device segment will be significant during the forecast period. Information Services Market Insights - Vendors: 15+, Including AbbVie Inc., Bayer AG, DKT International, Durbin PLC, EurimPharm Arzneimittel GmbH, EUROGINE SL, Gima Spa, HLL Lifecare Ltd., Krishco Medical Products Pvt. Ltd., Laboratoire HRA Pharma SAS, Melbea Innovations Ltd., Meril Life Sciences Pvt. Ltd., Ocon Medical Ltd., Pregna International Ltd, Prosan International BV, SMB Corp. of India, TESPRO LLC, The Cooper Companies Inc., TRIMEDIC SUPPLY NETWORK Ltd., Viatris Inc., among others Coverage: Parent market analysis; key drivers, major trends, and challenges; customer and vendor landscape; vendor product insights and recent developments; key vendors; and market positioning of vendors Segments: Type (Hormonal intrauterine device and Copper intrauterine device), End-user (Hospitals, Gynecology clinics, and Others), and Geography (North America, Europe, APAC, and Rest of World (ROW)) Insights on the market contribution of various segments, including country- and region-wise data, historic data (2017 to 2021), and forecast market size (2023 to 2027), request a sample report Intrauterine contraceptive devices (IUD) market - Customer Landscape To help companies evaluate and develop growth strategies, the report outlines – Key purchase criteria What are the key data covered in this Intrauterine Contraceptive Devices (IUD) Market report? CAGR of the market during the forecast period Detailed information on factors that will drive the growth of the Intrauterine Contraceptive Devices (IUD) Market between 2023 and 2027 Precise estimation of the size of the Intrauterine Contraceptive Devices (IUD) Market size and its contribution to the market in focus on the parent market Accurate predictions about upcoming trends and changes in consumer behavior Growth of the Intrauterine Contraceptive Devices (IUD) Market industry across North America, Europe, APAC, and Rest of World (ROW) A thorough analysis of the market's competitive landscape and detailed information about vendors Comprehensive analysis of factors that will challenge the growth of Intrauterine Contraceptive Devices (IUD) Market vendors Gain instant access to 17,000+ market research reports. Related Reports: Female Contraceptive Market - The Female Contraceptive Market is estimated to grow at a CAGR of 5.32% between 2022 and 2027. The size of the market is forecast to increase by USD 5,142.22 million. Emergency Contraceptive Pills Market - The emergency contraceptive pills market is estimated to grow at a CAGR of 4.83% between 2022 and 2027. The size of the market is forecast to increase by USD 258.7 million. Intrauterine Contraceptive Devices (IUD) Market Scope Report Coverage Key companies profiled AbbVie Inc., Bayer AG, DKT International, Durbin PLC, EurimPharm Arzneimittel GmbH, EUROGINE SL, Gima Spa, HLL Lifecare Ltd., Krishco Medical Products Pvt. Ltd., Laboratoire HRA Pharma SAS, Melbea Innovations Ltd., Meril Life Sciences Pvt. Ltd., Ocon Medical Ltd., Pregna International Ltd, Prosan International BV, SMB Corp. of India, TESPRO LLC, The Cooper Companies Inc., TRIMEDIC SUPPLY NETWORK Ltd., and Viatris Inc. Market dynamics Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period Customization purview If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. About Us Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios. Contact

OCON Medical Frequently Asked Questions (FAQ)

  • When was OCON Medical founded?

    OCON Medical was founded in 2011.

  • Where is OCON Medical's headquarters?

    OCON Medical's headquarters is located at Hamiktso’ot Blvd. 14, Modi'In.

  • What is OCON Medical's latest funding round?

    OCON Medical's latest funding round is Seed VC - II.

  • How much did OCON Medical raise?

    OCON Medical raised a total of $3.68M.

  • Who are the investors of OCON Medical?

    Investors of OCON Medical include Pontifax, Astia Angels, Rhia Ventures, Israel Innovation Authority, Docor International Management and 4 more.

  • Who are OCON Medical's competitors?

    Competitors of OCON Medical include Bayer and 2 more.

  • What products does OCON Medical offer?

    OCON Medical's products include IUB SEAD and 4 more.

Loading...

Compare OCON Medical to Competitors

A
Attgeno

Attgeno is a Stockholm-headquartered pharmaceutical company.

Growers Edge Logo
Growers Edge

Growers Edge provides financial technology and data solutions. It assists in decision-making and risk management in areas such as crop plans, credit and financing, and farmland valuation. The company serves agriculture retailers, input manufacturers, and farmers. It was formerly known as Crop Pro Insurance Services. The company was founded in 2016 and is based in Johnston, Iowa.

G
GynTools

GynTools develops microscopy-based diagnostic tools for women's health. It offers a patient-centric automated solution for detecting various diagnoses behind vaginal inflammation presenting with discharge, itch, or pain. It was founded in 2016 and is based in Jerusalem, Israel.

Qlarity Imaging Logo
Qlarity Imaging

Qlarity Imaging is a company that focuses on the development of artificial intelligence software in the healthcare sector. The company's main product is a decision support tool that assists radiologists in improving the diagnosis of breast abnormalities by analyzing data from MR images. The company primarily serves the healthcare industry. It was founded in 2018 and is based in Chicago, Illinois. Qlarity Imaging operates as a subsidiary of Paragon Biosciences.

B
Boehringer Ingelheim

Boehringer Ingelheim operates as a biopharmaceutical company. The company's main offerings include therapies in areas of high unmet medical need, spanning three business areas such as human pharma, animal health, and biopharmaceutical contract manufacturing. It primarily serves the pharmaceutical and healthcare industries. The company was founded in 1885 and is based in Ingelheim am Rhein, Germany.

C
CapeRay

CapeRay is a company that focuses on the development, manufacturing, and supply of medical imaging equipment, specifically in the domain of breast cancer diagnosis. The company's main product is an innovative imaging system that combines low dose digital x-rays and automated breast ultrasound in a single device, designed to provide complementary information for the early diagnosis of breast cancer, particularly in women with dense breast tissue. CapeRay primarily sells to the healthcare industry. It is based in Cape Town, South Africa.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.